Top Pharmaceutical Research Companies in Mexico
Compare top pharmaceutical research companies in Mexico for 2026. Find verified HCP panels and expert insights for your commercial strategy and market access.
Quick answer
For specialized patient journey mapping and HCP recruitment, Scopus Consulting; for large-scale international tracking, IQVIA; for high-quality qualitative fieldwork and local expertise, Fine Research; and for flexible, proprietary panel access across diverse therapeutic areas, Global Vox Populi.
Pharmaceutical brands operating in Mexico must work through a complex healthcare system defined by diverse institutional structures, including the IMSS and private sectors. Selecting from the available pharmaceutical research companies in Mexico requires an assessment of methodological rigour, respondent access, and adherence to regional data protection standards.
This evaluation focuses on providers capable of delivering evidence-based insights for prescriber, patient, and payer studies. Brands must balance the need for rapid local fieldwork with the precision required for high-stakes commercial decision-making in 2026. The following analysis provides a framework for evaluating these partners based on their ability to handle sensitive healthcare data and their reach among critical stakeholders in the Mexican market.
Top Pharmaceutical Research Companies in Mexico: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Multi-methodology international healthcare studies | 89.5 |
| 2 | IQVIA | Large-scale quantitative data and commercial analytics | 87.5 |
| 3 | Fine Research | High-quality quantitative and qualitative fieldwork execution | 82.0 |
| 4 | Ipsos Healthcare | Global brand health tracking and patient sentiment research | 80.0 |
| 5 | Scopus Consulting | Evidence-based physician panel studies and market modeling | 79.5 |
| 6 | Psyma Latina | Full-service market research with a focus on product life-cycle | 74.0 |
| 7 | ESR Research | Innovative qualitative fieldwork and patient-physician interactions | 73.5 |
| 8 | OnTarget | One-on-one customer and prospect interviewing | 65.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | HCPs, KOLs, patients, caregivers, payers, providers | Documented license validation and re-validation on rolling basis | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 64,224 healthcare professionals; 4,094 key opinion leaders; 706,675 patient profiles (in Mexico; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Physicians, patients, pharmacy partners, wholesalers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Fine Research | Healthcare practitioners, consumers | Proprietary database and local team validation | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos Healthcare | Physicians, patients, consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Scopus Consulting | Physicians, specialists | 100% validation of professional license and active practice | Not stated on pages reviewed | Not published | 1,000+ physicians (scopusconsulting.com.mx, Oct 2026) | Not published |
| Psyma Latina | Physicians, medical professionals | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| ESR Research | Patients, physicians | Verified databases and own telephone recruitment process | ESOMAR | Not published | Not published | Not published |
| OnTarget | Customers, prospects | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | ● | – | – | ● | – | ● |
| Fine Research | ● | ● | ● | ● | ● | ● |
| Ipsos Healthcare | ● | ● | – | ● | – | ● |
| Scopus Consulting | ● | – | ● | ● | – | – |
| Psyma Latina | ● | ● | – | ● | – | – |
| ESR Research | ● | ● | – | ● | – | – |
| OnTarget | ● | ● | ● | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Apply a standardized scorecard to protect consistent comparison of technical capabilities and compliance standards.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of knowledge regarding the Mexican healthcare environment, including the specific operational nuances of public and private health systems. High-scoring agencies possess deep experience in working through the regulatory, cultural, and professional dynamics that influence prescriber and patient behaviors within the local market. |
| Compliance, Certifications and Security | 20 | This evaluates the agency's adherence to data protection laws and industry codes such as ESOMAR. It covers the presence of ISO certifications and formal procedures for managing sensitive health data, specifically the mandatory protocols for tracking and reporting adverse events during any pharmaceutical study. |
| Target Audience Reach | 15 | This assesses the ability to access specific HCP specialties, patient profiles, and payer roles. Excellence here requires verified proprietary panels that allow for precise targeting of low-incidence groups without relying on third-party brokers, making sure the sample reflects the actual composition of the target population. |
| Research Quality | 10 | This gauges the rigour of questionnaire design, sampling strategy, and data validation processes. A strong agency implements multi-stage quality controls, including device fingerprinting and trap questions, to eliminate fraudulent completes and make sure that every data point is reliable for high-stakes business decisions. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This looks at the range of available research tools, from qualitative methods like ethnography and in-depth interviews to quantitative tools like CATI and online tracking. A versatile provider offers multiple modes of engagement to suit different study objectives, whether exploring patient motivations or measuring brand performance. |
| Analytical Capability | 5 | This evaluates the ability to synthesize raw data into strategic recommendations. The best partners move beyond reporting frequencies to identify causal drivers of behavior, enabling clear business actions such as brand repositioning or the optimization of sales force messaging in the competitive Mexican environment. |
| Client Service and Speed | 5 | This assesses the responsiveness and project management effectiveness of the agency. High performance involves transparent communication regarding project timelines, proactive handling of field challenges, and the ability to deliver actionable toplines efficiently without compromising the underlying quality of the research data. |
| Pricing and Feasibility Transparency | 5 | This measures the provider's willingness to share realistic incidence rates, feasibility estimates, and cost structures before fieldwork begins. Honest agencies report what is achievable based on their actual panel strength, avoiding the temptation to overpromise on sample sizes for hard-to-reach medical audiences. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in Mexico
Global Vox Populi: best for multi-methodology international healthcare studies
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitGlobal brands requiring high-compliance research and access to hard-to-reach medical audiences.
Global Vox Populi functions as a primary research partner with a strong focus on healthcare and pharmaceutical sectors. The firm operates its own proprietary panels and manages fieldwork internationally, maintaining a significant presence in Mexico to serve global brands with high-quality, verified data.
The agency is distinguished by its commitment to compliance and data integrity, using healthcare market research in Mexico to provide actionable insights. Its infrastructure allows for complex, low-incidence targeting across diverse medical specialties, making sure that research meets the strict requirements of pharmaceutical clients.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Mexico
64,224 panellists
- Primary & General26,316
- Internal Medicine Subspecialties5,436
- Acute, Peri-operative & Critical Care4,782
- Diagnostic & Laboratory4,528
- Women's & Reproductive Health4,392
- Surgical Specialties3,976
Key opinion leader panel, in Mexico
4,094 panellists
- Internal Medicine Subspecialties770
- Primary & General539
- Surgical Specialties476
- Diagnostic & Laboratory413
- Acute, Peri-operative & Critical Care308
- Nervous System & Mental Health275
Patient panel, in Mexico
706,675 patient profiles
- Aesthetics & Cosmetic236,716
- Cardiovascular45,339
- Women's Health38,454
- Dermatology36,437
- Endocrinology & Metabolic35,439
- Preventive & Vaccine-preventable32,802
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Mexico
1,245 panellists
- Provider: Access & Administrative Roles797
- Payer: Access & Coverage Roles448
Scorecard: 89.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 89.5 |
Core services
- Proprietary Panel Access: Access to healthcare professionals, key opinion leaders, patients, and payers.
- Full-Service Fieldwork: Execution of quantitative and qualitative studies using internal platforms and managed fieldwork partners.
- Compliance and Quality: ISO 9001, 20252, and 27001 certified operations with dedicated adverse event reporting procedures.
Strengths
- Proprietary Healthcare Panels: Owns verified panels including 64,224 HCPs and 706,675 patient profiles in Mexico.
- Rigorous Data Quality: Implements device fingerprinting, trap questions, and fraud detection to protect reliable data.
- Compliance Standards: Operates under HIPAA, GDPR, and international codes, with formal adverse event reporting.
Innovation and technology
- Advanced Profiling: Profiles members on up to 140 data points to support highly specific targeting.
- Platform Integration: Surveys are programmed and hosted on a proprietary platform to control data flow.
Impact on businesses
- Strategic Decision Support: Provides clear, verified data to support commercial strategy and brand performance assessment.
- Risk Mitigation: Makes sure all research activities meet pharmaceutical compliance and ethical standards.
Why it may fit your brief
The firm is well-suited for briefs requiring deep panel penetration and stringent adherence to international compliance standards. For projects focused solely on local, small-scale qualitative logistics, other boutique local partners may offer more localized facility management.
IQVIA: best for large-scale quantitative data and commercial analytics
Strongest fitGlobal pharmaceutical firms requiring large-scale data modeling and commercial performance tracking.
IQVIA provides a comprehensive suite of data-driven solutions for the pharmaceutical industry, integrating advanced analytics and technology to support commercial execution. In Mexico, the firm offers broad market insights, physician and patient data analytics, and strategic consulting.
The agency uses massive proprietary datasets to model market opportunities and track performance. Its approach emphasizes the connection between clinical development and commercial success, offering tools that help brands monitor market dynamics and patient adherence.
Scorecard: 87.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 87.5 |
Core services
- Commercial Analytics: Provides data and dashboards to monitor performance and market share against benchmarks.
- Clinical Development Support: Offers functional service provider models and clinical trial site intelligence.
- Strategic Consulting: Consults on tactical and strategic challenges related to payer dynamics and pharmacy performance.
Strengths
- Data Infrastructure: Access to petabytes of proprietary data and non-identified patient records.
- Market Intelligence: Tracks a significant percentage of global pharmaceutical sales to inform decision-making.
Innovation and technology
- Artificial Intelligence: Uses agentic AI platforms to predict market outcomes and optimize sales force deployment.
Impact on businesses
- Asset Maximization: Helps brands maximize the probability of success in complex, competitive environments.
Why it may fit your brief
IQVIA is ideal for clients needing large, longitudinal datasets and sophisticated market analytics. For small, ad-hoc qualitative studies, its infrastructure may be more extensive than required.
Fine Research: best for high-quality quantitative and qualitative fieldwork execution
Strongest fitInternational agencies and brands requiring reliable fieldwork execution and HCP access in Mexico.
Fine Research is an independent data collection agency focusing on Latin America. The firm specializes in healthcare fieldwork, offering quantitative and qualitative solutions supported by local teams and proprietary panels.
The agency serves as a partner for international research companies and pharmaceutical brands, executing over 500 projects annually. Its focus on operational scale and local expertise protects consistency across the Mexican market.
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- Quantitative Fieldwork: Conducts large-scale online surveys and tracker projects.
- Qualitative Recruitment: Provides specialized recruitment for focus groups, IDIs, and communities.
- Regional Coordination: Manages multi-country projects with consistent local execution.
Strengths
- Regional Fieldwork Scale: Extensive network of local teams and proprietary panels across Latin America.
- Healthcare Expertise: Specialized teams trained in healthcare methodologies and pharmacovigilance.
Innovation and technology
- Proprietary Panels: Maintains a large, profiled database of healthcare practitioners.
Impact on businesses
- Operational Consistency: Enables global partners to execute research consistently across the region.
Why it may fit your brief
Fine Research is ideal for firms needing high-quality data collection and specialized recruitment. It acts as an operational partner, which is perfect for clients who already have an internal analytics and strategy team.
Ipsos Healthcare: best for global brand health tracking and patient sentiment research
Strongest fitLarge organizations needing consistent brand tracking across multiple international markets.
Ipsos Healthcare delivers market research and advisory services through a dedicated division. In Mexico, the team conducts quantitative and qualitative studies, focusing on the experiences of patients, physicians, and citizens to help brands understand market trends.
The agency combines survey data with social media analysis and qualitative research to provide actionable insights. Its global reach allows for consistent international tracking, helping clients work through healthcare systems across different markets.
Scorecard: 80.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.0 |
Core services
- Brand Health Tracking: Monitors brand performance and perceptions across markets.
- Patient Journey Mapping: Analyzes the experiences and opinions of patients to identify barriers and opportunities.
- Market Strategy: Provides research to support smarter decision-making in market development.
Strengths
- Global Methodology: Standardized global approaches for tracking perceptions and market trends.
- Diverse Data Sources: Uses data from surveys, social media, and qualitative sources for holistic insights.
Innovation and technology
- AI Integration: Uses AI to process survey data and deliver insights more consistently.
Impact on businesses
- Strategic Clarity: Helps clients act faster and bolder by providing accurate, relevant information.
Why it may fit your brief
Ipsos excels in large-scale brand tracking and public opinion research. For highly localized, niche physician recruitment in Mexico, a more specialized local partner may provide faster results.
Scopus Consulting: best for evidence-based physician panel studies and market modeling
Strongest fitBrands needing highly verified physician data and evidence-based market sizing in Mexico.
Scopus Consulting focuses exclusively on the pharmaceutical market in Mexico and Latin America. The firm designs studies and executes fieldwork using its own verified physician panel to provide evidence-based insights.
The agency emphasizes transparency in its methods, publishing details on recruitment and quality control. Its services are designed to answer business questions through rigorous modeling and longitudinal tracking, helping clients justify investments with clear data.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | scopusconsulting.com.mx (5 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Physician Panel Studies: Provides verified physician data for market research.
- Market Modeling: Builds sizing models for patients by indication and biomarker.
- Longitudinal Tracking: Conducts brand trackers on fixed panels to measure market movement.
Strengths
- Verified Physician Panel: 100% validation of professional credentials and active clinical practice.
- Transparent Protocols: Publishes detailed methodologies, including sampling and margin of error.
Innovation and technology
- Longitudinal Tracking: Maintains fixed panels to protect comparable data over time.
Impact on businesses
- Decision Support: Provides actionable recommendations to support marketing and sales investments.
Why it may fit your brief
Scopus is ideal for clients who demand high transparency and verified physician samples. Its focus is narrow, making it less suitable for broad consumer or non-medical market research.
Psyma Latina: best for full-service market research with a focus on product life-cycle
Strongest fitBrands seeking a long-term partner for full-service research and strategic advisory.
Psyma Latina provides research and consulting for the pharmaceutical and medical technology sectors. The team focuses on understanding human motives and market-relevant behavior, supporting clients through every phase of the product life cycle.
The agency emphasizes a ‘business issue first’ approach, combining research design, data collection, and analysis with strategic consulting. Its work in Mexico is supported by a global network that enables consistent research methodologies.
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Market Potential Evaluation: Assesses market potential to support strategic business decisions.
- Product Life-Cycle Research: Provides research and consulting throughout the entire product life cycle.
- Insights Consulting: Translates research findings into actionable recommendations for marketing teams.
Strengths
- Full-Service Approach: Handles projects from initial design through to final insights delivery.
- Strategic Focus: Focuses on providing actionable recommendations rather than just raw data.
Innovation and technology
- Digital Research Tools: Uses various digital formats to capture behavioral data.
Impact on businesses
- Marketing Support: Provides insights to support effective marketing decisions and business growth.
Why it may fit your brief
Psyma is well-suited for clients wanting a partner to manage the full research process. Those needing only specialized, high-speed fieldwork execution might consider dedicated fieldwork agencies.
ESR Research: best for innovative qualitative fieldwork and patient-physician interactions
Strongest fitBrands requiring high-quality qualitative fieldwork and specialized facility-based research.
ESR Research provides fieldwork and market intelligence services across various sectors, including health and well-being. The team uses both traditional and innovative methodologies to engage target customers, focusing on precision and technology.
The agency maintains specialized meeting rooms and recruitment processes to support high-quality qualitative research. Its approach includes a wide range of techniques, such as virtual groups and ethnography, to understand the nuances of different markets.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Qualitative Fieldwork: Provides specialized moderation and meeting facilities for focus groups and IDIs.
- Quantitative Fieldwork: Conducts CATI, CAPI, and CAWI studies.
- Patient-Physician Research: Specializes in research exploring interactions between patients and physicians.
Strengths
- Facility Infrastructure: Offers well-equipped meeting rooms for qualitative research.
- Methodological Variety: Combines traditional and modern methods including AI and UX research.
Innovation and technology
- Virtual Research: Extensive use of virtual IDIs and online qualitative techniques.
Impact on businesses
- Competitive Advantage: Assists clients in resolving brand, product, and market issues.
Why it may fit your brief
ESR is ideal for qualitative studies involving complex interactions. For purely quantitative, large-scale physician tracking, an agency with a larger proprietary quantitative panel might be preferred.
OnTarget: best for one-on-one customer and prospect interviewing
Strongest fitBrands seeking direct feedback from customers and prospects through live interviews.
OnTarget provides fieldwork services with a focus on one-on-one interviews. The firm has a long history of conducting research to help clients improve advertising effectiveness and customer loyalty.
The agency avoids focus groups, preferring direct, live interviews to capture customer and prospect feedback. This approach is applied across various sectors, including nutrition and health, to provide clear, actionable feedback for marketing and positioning strategies.
Scorecard: 65.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 6/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ontargetresearch.com (5 pages reviewed), Oct 2026 |
| Weighted score | 100 | 65.5 |
Core services
- One-on-One Interviews: Conducts live interviews in person or via telephone.
- Customer Surveys: Measures customer satisfaction and loyalty.
- Positioning Research: Provides insights to drive market positioning strategies.
Strengths
- Direct Feedback: Focuses on live interviews to get deep, honest feedback from respondents.
- Specialized Fieldwork: Deep experience in surveying hard-to-reach publics.
Innovation and technology
- Interview Methodology: Rejects focus groups in favor of direct, personalized engagement.
Impact on businesses
- Marketing Effectiveness: Helps clients advertise more effectively and convert leads.
Why it may fit your brief
OnTarget is best for clients who value direct, one-on-one engagement. For studies requiring complex medical panel access or quantitative tracking, other providers might be more suitable.
How HCP and patient verification actually works in Mexico
Demand documented proof of professional credentialing and active clinical practice for all healthcare research participants.
Professional Credential Validation
In Mexico, healthcare research requires validating the professional license (Cédula Profesional) of every physician. Agencies should cross-reference this against official government registries to confirm the respondent is a legitimate practitioner. Do not accept self-reported credentials without documented verification. Ask the provider for their verification protocol: do they check the medical registry? How often do they re-verify? A provider that cannot produce a clear, documented audit trail of their panel recruitment process is a significant compliance risk for your research project.
How to choose the right provider in Mexico
Assess the provider's ability to balance local regulatory knowledge with the specific methodological requirements of your study.
- Define Research Objectives: Clearly distinguish between studies requiring deep qualitative insights and those needing broad quantitative data. This dictates whether you prioritize a boutique agency with specialized moderators or a firm with extensive panel reach.
- Evaluate Compliance Protocols: Verify the agency's ability to perform mandatory adverse event reporting. This is a standard requirement in the pharmaceutical sector and must be confirmed before any fieldwork begins.
- Review Panel Provenance: Ask if the panel is owned and managed by the agency or rented from third-party sources. Owned panels generally offer better control over data quality and verification consistency.
- Check Local Knowledge: Confirm the agency understands the nuances of the Mexican healthcare system, including the differences between public institutions like IMSS and private providers. This knowledge is essential for accurate market access and patient journey research.
- Audit Data Quality: Inquire about the specific technical controls in place, such as device fingerprinting and fraud detection. These measures are necessary to protect the integrity of the collected data.
Questions to ask before you commission
- What specific process do you use to verify the medical credentials of your physician participants in Mexico?
- Can you provide a documented protocol for how you handle and report adverse events during patient research?
- How do you make sure your panel members are active in the specific therapeutic areas required for this study?
- What technical controls (e.g., bot detection, geo-checks) are implemented during data collection to prevent fraudulent completes?
- Are you able to provide a detailed breakdown of your sample composition, including institutional representation, before we start fieldwork?
- How does your agency handle the specific challenges of low-incidence medical specialties in the Mexican market?
Common pitfalls to avoid
- Ignoring Verification Standards: Relying on unverified panels can lead to poor-quality data from individuals who do not accurately represent the target medical audience.
- Overlooking Local Context: Assuming that global research methodologies will work without adaptation to the unique institutional structure of Mexico's healthcare system.
- Neglecting Compliance Documentation: Failing to establish clear adverse event reporting procedures before fieldwork starts, which creates significant regulatory risk.
- Prioritizing Speed Over Quality: Accepting overly optimistic feasibility estimates that ignore the difficulty of recruiting specialized medical professionals in the local market.
What a feasibility check should include
Always require a feasibility study that includes specific incidence rates and recruitment timelines for your exact target audience.
Incidence Rate Analysis
The agency must provide a realistic assessment of how many physicians or patients meet your specific criteria. This prevents delays caused by overly optimistic recruitment targets.
Institutional Access Check
The check should confirm if the agency can access the required mix of public and private sector professionals. This makes sure the sample is representative of the actual market environment.
Timeline Validation
A proper assessment should include a clear schedule for recruitment and field execution. This allows for proactive planning in case of unexpected recruitment challenges.
Protocol Feasibility
The provider must confirm that the proposed study length and methodology are acceptable to the target audience. This avoids drop-offs and protects high-quality responses.
Conclusion
Selecting the right partner among pharmaceutical research companies in Mexico depends on your specific project goals. For large-scale tracking and deep commercial analytics, agencies with extensive data infrastructure are optimal. If your brief requires precise qualitative insights or hard-to-reach medical audiences, prioritize firms with verified proprietary panels and transparent recruitment protocols.
Use the scorecard provided to evaluate providers based on their industry expertise and compliance standards. Make sure that any agency you select can demonstrate a clear, documented process for verifying professional credentials and handling adverse events. By focusing on these non-negotiable quality and compliance markers, you will secure reliable, evidence-based insights that drive success in the competitive Mexican healthcare market.
Planning research in Mexico? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top pharmaceutical market research companies in Mexico?
The market includes several specialized providers such as IQVIA, Ipsos Healthcare, Psyma Latina, Fine Research, OnTarget, ESR Research, Scopus Consulting, and Global Vox Populi. The 'best' choice depends on your specific needs, such as large-scale quantitative tracking, specialized physician recruitment, or qualitative patient journey studies.
How to conduct pharmaceutical market research in Mexico?
Conducting research in Mexico requires a structured approach: defining clear objectives, selecting a partner with a verified local panel, protecting compliance with local data laws, and implementing rigorous quality controls during fieldwork. It is essential to account for the unique public and private healthcare sectors when designing the study.
Which market research agencies specialize in the Mexican healthcare sector?
Several agencies have dedicated healthcare divisions or specialize exclusively in the sector, including Scopus Consulting, Fine Research, and Global Vox Populi. These firms focus on the complexities of the Mexican medical market, offering targeted recruitment of physicians, patients, and healthcare providers.
Are there local market research firms for pharma in Mexico City?
Yes, many of the listed agencies, such as Scopus Consulting, Psyma Latina, and Fine Research, have established operations or teams in Mexico City. These local presences allow them to coordinate fieldwork, manage qualitative facilities, and maintain a deep understanding of the local healthcare environment.
How large is the pharmaceutical market research industry in Mexico?
The industry is extensive, driven by the need for global pharmaceutical brands to understand the Mexican market's specific institutional and patient dynamics. While specific revenue figures are not published, the depth of available expertise and the presence of major international and specialized local players indicate a significant and active market.
What is the role of COFEPRIS in pharmaceutical market research?
COFEPRIS is the regulatory authority responsible for health oversight in Mexico. While it does not directly manage market research, it sets the standards for healthcare practice and product safety. Research agencies must protect their studies respect these standards, particularly regarding pharmacovigilance and adverse event reporting.
Who are the leading healthcare research providers in Latin America?
Leading providers in Latin America include agencies with broad regional footprints like Fine Research, Ipsos, and IQVIA. These firms use local teams and proprietary panels across multiple countries to provide consistent research data for pharmaceutical brands operating throughout the region.
What are the most common challenges in pharmaceutical research in Mexico?
Common challenges include recruiting low-incidence medical specialties, working through the differences between IMSS and private patient populations, and making sure that fieldwork is compliant with strict local and international data protection and safety reporting regulations.